Novartis AG (NVS)
141.02
+0.65
(+0.46%)
USD |
NYSE |
Sep 21, 16:00
141.02
0.00 (0.00%)
After-Hours: 20:00
Novartis Total Return Level : 314.18 for Sept. 18, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 18, 2026 | 314.18 |
| September 17, 2026 | 315.41 |
| September 16, 2026 | 310.44 |
| September 15, 2026 | 310.27 |
| September 14, 2026 | 311.09 |
| September 11, 2026 | 307.00 |
| September 10, 2026 | 307.71 |
| September 09, 2026 | 307.71 |
| September 08, 2026 | 308.21 |
| September 04, 2026 | 358.10 |
| September 03, 2026 | 365.04 |
| September 02, 2026 | 363.63 |
| September 01, 2026 | 360.92 |
| August 31, 2026 | 340.35 |
| August 28, 2026 | 344.26 |
| August 27, 2026 | 346.14 |
| August 26, 2026 | 352.61 |
| August 25, 2026 | 358.07 |
| August 24, 2026 | 353.69 |
| August 21, 2026 | 355.57 |
| August 20, 2026 | 349.70 |
| August 19, 2026 | 358.81 |
| August 18, 2026 | 345.92 |
| August 17, 2026 | 340.15 |
| August 14, 2026 | 337.71 |
| Date | Value |
|---|---|
| August 13, 2026 | 339.59 |
| August 12, 2026 | 340.93 |
| August 11, 2026 | 346.06 |
| August 10, 2026 | 350.93 |
| August 07, 2026 | 349.91 |
| August 06, 2026 | 345.16 |
| August 05, 2026 | 345.67 |
| August 04, 2026 | 343.06 |
| August 03, 2026 | 343.95 |
| July 31, 2026 | 349.50 |
| July 30, 2026 | 354.63 |
| July 29, 2026 | 355.50 |
| July 28, 2026 | 357.78 |
| July 27, 2026 | 349.41 |
| July 24, 2026 | 346.95 |
| July 23, 2026 | 349.48 |
| July 22, 2026 | 342.63 |
| July 21, 2026 | 344.40 |
| July 20, 2026 | 334.75 |
| July 17, 2026 | 344.15 |
| July 16, 2026 | 341.85 |
| July 15, 2026 | 337.53 |
| July 14, 2026 | 336.54 |
| July 13, 2026 | 343.28 |
| July 10, 2026 | 344.80 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Roche Holding AG | 105.91 |
| AstraZeneca PLC | 419.21 |
| GSK Plc | 191.51 |
| Johnson & Johnson | 644.25 |
| Eli Lilly & Co. | 3046.28 |